Entity Common Stock, Shares Outstanding of Taysha Gene Therapies, Inc. from 12 Nov 2020 to 04 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Taysha Gene Therapies, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 12 Nov 2020 to 04 Nov 2025.
  • Taysha Gene Therapies, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 04 Nov 2025 was 273,919,373, a 34% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Taysha Gene Therapies, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 273,919,373 +68,976,067 +34% 04 Nov 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 272,794,885 +67,851,579 +33% 12 Aug 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 205,001,632 +17,983,357 +9.6% 26 Feb 2025 10-K 26 Feb 2025 2024 FY
Q3 2024 204,943,306 +17,983,113 +9.6% 13 Nov 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 204,943,306 +140,478,269 +218% 12 Aug 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 187,018,275 +123,544,926 +195% 19 Mar 2024 10-K 19 Mar 2024 2023 FY
Q3 2023 186,960,193 +124,517,912 +199% 14 Nov 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 64,465,037 +23,371,878 +57% 14 Aug 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 63,473,349 +24,999,404 +65% 28 Mar 2023 10-K 28 Mar 2023 2022 FY
Q3 2022 62,442,281 +23,968,336 +62% 08 Nov 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 41,093,159 11 Aug 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 38,473,945 +712,510 +1.9% 31 Mar 2022 10-K 31 Mar 2022 2021 FY
Q3 2021 38,473,945 +712,510 +1.9% 10 Nov 2021 10-Q 10 Nov 2021 2021 Q3
Q1 2021 37,761,435 03 Mar 2021 10-K 03 Mar 2021 2020 FY
Q3 2020 37,761,435 12 Nov 2020 10-Q 12 Nov 2020 2020 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.